RIGEL PHARMACEUTICALS INC RIGL

Latest FY: 2025 Healthcare Biotechnology
Market Price $47.22
Market Cap $873.67M
P/E Ratio 2.42
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑64.1% YoY
$294.28M
3-Yr CAGR: 34.8%
Net Income ↑1,999.1% YoY
$367.02M
Net Margin: 124.7%
Free Cash Flow ↑140.7% YoY
$75.66M
FCF Yield: 8.66%
EPS (Diluted) ↑1,867.7% YoY
$19.48
Basic: $20.40
Return on Equity Efficiency
93.8%
ROA: 71.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (RIGL)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $20.4M $-48.8M $-69.2M 0.00% $-75.9M $-76.7M
FY 2017 $4.5M -78.0% $-41.8M $-78.0M -12.7% 0.00% $-77.6M $-77.7M -1.3%
FY 2018 $44.5M +892.6% $44.2M $-70.5M +9.6% 0.00% $-58.8M $-59.9M +22.9%
FY 2019 $59.3M +33.2% $58.4M $-66.9M +5.1% 0.00% $-41.5M $-43.0M +28.3%
FY 2020 $108.6M +83.2% $107.3M $-29.7M +55.5% 0.00% $-52.2M $-53.4M -24.4%
FY 2021 $149.2M +37.4% $144.4M $-17.9M +39.8% $-0.11 0.00% $5.9M $5.3M +109.8%
FY 2022 $120.2M -19.4% $116.5M $-58.6M -227.0% $-0.34 -209.1% 0.00% $-73.8M $-74.2M -1,513.2%
FY 2023 $116.9M -2.8% $109.8M $-25.1M +57.2% $-0.14 +58.8% 0.00% $-5.7M $-5.7M +92.3%
FY 2024 $179.3M +53.4% $160.6M $17.5M +169.7% $0.99 +807.1% 0.00% $31.5M $31.4M +647.4%
FY 2025 $294.3M +64.1% $274.7M $367.0M +1,999.1% $19.48 +1,867.7% 0.00% $75.7M $75.7M +140.7%
$

Valuation

Market Price $47.22
Market Cap $873.67M
Enterprise Value $885.59M
P/E Ratio 2.42
P/B Ratio 2.23
FCF Yield 8.66%
Dividend Yield N/A
Shares Outstanding 18,502,100
%

Profitability & Margins

Gross Margin 93.33%
Operating Margin 42.63%
Net Margin 124.72%
Return on Equity (ROE) 93.75%
Return on Assets (ROA) 71.46%
Asset Turnover 0.57x
Revenue 3-Yr CAGR 34.76%
🛡️

Financial Health & Liquidity

Current Ratio 2.42
Cash Ratio 0.41
Debt / Equity 0.134
Debt / Assets 0.102
Cash & Equivalents $40.58M
Total Debt $52.50M
Book Value / Share $21.16
💧

Cash Flow Efficiency

Operating Cash Flow $75.66M
Capital Expenditures (CapEx) N/A
Free Cash Flow $75.66M
OCF / Revenue 25.71%
FCF / Revenue 25.71%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $19.48
EPS (Basic) $20.40
Dividends / Share N/A
Book Value / Share $21.16
EPS YoY Growth 1,867.68%
🏛️

Balance Sheet (FY 2025)

Total Assets $513.59M
Total Liabilities $122.11M
Stockholders' Equity $391.48M
Current Assets $240.17M
Current Liabilities $99.24M